Rubraca Alternatives Compared
| Rubraca (rucaparib) | Lupron Depot (leuprolide) | Lynparza (olaparib) |
|
|---|
| Rubraca (rucaparib) | Lupron Depot (leuprolide) | Lynparza (olaparib) |
|
|||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ovarian Cancer, Prostate Cancer. Rubraca may also be used for purposes not listed in this medication guide. |
Prescription only
Lupron Depot is a hormone deprivation treatment that may be used for the palliative care of advanced prostate cancer. The main side effects are hot flashes and general pain and it may cause... View more |
Prescription only
Prescribed for Ovarian Cancer, Breast Cancer - Metastatic, Breast Cancer, Prostate Cancer, Pancreatic Cancer. Lynparza may also be used for purposes not listed in this medication guide. |
Related suggestionsProstate Cancer |
|||||||||||||||||||||||||||||
| More about Rubraca (rucaparib) | More about Lupron Depot (leuprolide) | More about Lynparza (olaparib) | ||||||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Lupron Depot has an average rating of 6.0 out of 10 from a total of 265 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 29% reported a negative effect. |
Lynparza has an average rating of 7.5 out of 10 from a total of 18 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||||||||
|
View all 265 reviews |
View all 18 reviews |
|||||||||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||||||||
|
View all side effects |
View all side effects |
View all side effects |
||||||||||||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | ||||||||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | ||||||||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||||||||
|
N/A |
Other leuprolide brands include: Camcevi, Camcevi ETM, Eligard, Fensolvi, Lupron, Lupron Depot-PED, Lutrate Depot, Vobrig View more |
N/A |
||||||||||||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | ||||||||||||||||||||||||||||||||
|
26 hours |
4.25 hours |
11.9 hours |
||||||||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category X
See the full pregnancy warnings document. |
Category D
See the full pregnancy warnings document. |
||||||||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||||||||
|
A total of 763 drugs are known to interact with Rubraca:
|
A total of 298 drugs are known to interact with Lupron Depot:
|
A total of 657 drugs are known to interact with Lynparza:
|
||||||||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||||||||
|
December 19, 2016 |
January 26, 1989 |
December 19, 2014 |
||||||||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.